vs

Side-by-side financial comparison of CLEAN HARBORS INC (CLH) and Revvity (RVTY). Click either name above to swap in a different company.

CLEAN HARBORS INC is the larger business by last-quarter revenue ($1.5B vs $772.1M, roughly 1.9× Revvity). Revvity runs the higher net margin — 12.7% vs 5.8%, a 7.0% gap on every dollar of revenue. On growth, Revvity posted the faster year-over-year revenue change (5.9% vs 4.8%). CLEAN HARBORS INC produced more free cash flow last quarter ($233.3M vs $161.8M). Over the past eight quarters, Revvity's revenue compounded faster (9.0% CAGR vs 4.4%).

Clean Harbors, Inc., headquartered in Norwell, Massachusetts, is a provider of waste management and industrial services for commercial customers, specializing in the collection, transportation, treatment and disposal of hazardous waste, but also offering services for non-hazardous waste. The company has 870 operating locations in 630 properties in the U.S. and Canada including a network of over 100 waste disposal facilities such as incinerators, landfills, treatment, storage and disposal faci...

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.

CLH vs RVTY — Head-to-Head

Bigger by revenue
CLH
CLH
1.9× larger
CLH
$1.5B
$772.1M
RVTY
Growing faster (revenue YoY)
RVTY
RVTY
+1.1% gap
RVTY
5.9%
4.8%
CLH
Higher net margin
RVTY
RVTY
7.0% more per $
RVTY
12.7%
5.8%
CLH
More free cash flow
CLH
CLH
$71.6M more FCF
CLH
$233.3M
$161.8M
RVTY
Faster 2-yr revenue CAGR
RVTY
RVTY
Annualised
RVTY
9.0%
4.4%
CLH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLH
CLH
RVTY
RVTY
Revenue
$1.5B
$772.1M
Net Profit
$86.6M
$98.4M
Gross Margin
30.6%
Operating Margin
10.6%
14.5%
Net Margin
5.8%
12.7%
Revenue YoY
4.8%
5.9%
Net Profit YoY
3.1%
3.9%
EPS (diluted)
$1.62
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLH
CLH
RVTY
RVTY
Q4 25
$1.5B
$772.1M
Q3 25
$1.5B
$698.9M
Q2 25
$1.5B
$720.3M
Q1 25
$1.4B
$664.8M
Q4 24
$1.4B
$729.4M
Q3 24
$1.5B
$684.0M
Q2 24
$1.6B
$691.7M
Q1 24
$1.4B
$649.9M
Net Profit
CLH
CLH
RVTY
RVTY
Q4 25
$86.6M
$98.4M
Q3 25
$118.8M
$46.7M
Q2 25
$126.9M
$53.9M
Q1 25
$58.7M
$42.2M
Q4 24
$84.0M
$94.6M
Q3 24
$115.2M
$94.4M
Q2 24
$133.3M
$55.4M
Q1 24
$69.8M
$26.0M
Gross Margin
CLH
CLH
RVTY
RVTY
Q4 25
30.6%
Q3 25
32.3%
53.6%
Q2 25
33.3%
54.5%
Q1 25
28.6%
56.5%
Q4 24
29.9%
Q3 24
31.0%
56.3%
Q2 24
33.3%
55.7%
Q1 24
29.5%
54.6%
Operating Margin
CLH
CLH
RVTY
RVTY
Q4 25
10.6%
14.5%
Q3 25
12.5%
11.7%
Q2 25
13.6%
12.6%
Q1 25
7.8%
10.9%
Q4 24
9.6%
16.3%
Q3 24
12.6%
14.3%
Q2 24
13.9%
12.4%
Q1 24
9.1%
6.8%
Net Margin
CLH
CLH
RVTY
RVTY
Q4 25
5.8%
12.7%
Q3 25
7.7%
6.7%
Q2 25
8.2%
7.5%
Q1 25
4.1%
6.4%
Q4 24
5.9%
13.0%
Q3 24
7.5%
13.8%
Q2 24
8.6%
8.0%
Q1 24
5.1%
4.0%
EPS (diluted)
CLH
CLH
RVTY
RVTY
Q4 25
$1.62
$0.86
Q3 25
$2.21
$0.40
Q2 25
$2.36
$0.46
Q1 25
$1.09
$0.35
Q4 24
$1.55
$0.77
Q3 24
$2.12
$0.77
Q2 24
$2.46
$0.45
Q1 24
$1.29
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLH
CLH
RVTY
RVTY
Cash + ST InvestmentsLiquidity on hand
$127.4M
$919.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$7.3B
Total Assets
$7.6B
$12.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLH
CLH
RVTY
RVTY
Q4 25
$127.4M
$919.9M
Q3 25
$91.2M
$931.4M
Q2 25
$98.9M
$991.8M
Q1 25
$105.9M
$1.1B
Q4 24
$102.6M
$1.2B
Q3 24
$82.4M
$1.2B
Q2 24
$91.3M
$2.0B
Q1 24
$104.8M
$1.7B
Stockholders' Equity
CLH
CLH
RVTY
RVTY
Q4 25
$2.7B
$7.3B
Q3 25
$2.8B
$7.4B
Q2 25
$2.7B
$7.6B
Q1 25
$2.6B
$7.6B
Q4 24
$2.6B
$7.7B
Q3 24
$2.5B
$7.9B
Q2 24
$2.4B
$7.9B
Q1 24
$2.3B
$7.8B
Total Assets
CLH
CLH
RVTY
RVTY
Q4 25
$7.6B
$12.2B
Q3 25
$7.5B
$12.1B
Q2 25
$7.4B
$12.4B
Q1 25
$7.2B
$12.4B
Q4 24
$7.4B
$12.4B
Q3 24
$7.3B
$12.8B
Q2 24
$7.1B
$13.4B
Q1 24
$6.9B
$13.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLH
CLH
RVTY
RVTY
Operating Cash FlowLast quarter
$355.1M
$182.0M
Free Cash FlowOCF − Capex
$233.3M
$161.8M
FCF MarginFCF / Revenue
15.6%
21.0%
Capex IntensityCapex / Revenue
8.1%
2.6%
Cash ConversionOCF / Net Profit
4.10×
1.85×
TTM Free Cash FlowTrailing 4 quarters
$441.8M
$509.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLH
CLH
RVTY
RVTY
Q4 25
$355.1M
$182.0M
Q3 25
$302.0M
$138.5M
Q2 25
$208.0M
$134.3M
Q1 25
$1.6M
$128.2M
Q4 24
$303.9M
$174.2M
Q3 24
$239.2M
$147.9M
Q2 24
$216.0M
$158.6M
Q1 24
$18.5M
$147.6M
Free Cash Flow
CLH
CLH
RVTY
RVTY
Q4 25
$233.3M
$161.8M
Q3 25
$207.5M
$120.0M
Q2 25
$118.0M
$115.5M
Q1 25
$-117.1M
$112.2M
Q4 24
$241.5M
$149.8M
Q3 24
$142.4M
$125.6M
Q2 24
$80.9M
$136.6M
Q1 24
$-119.4M
$129.7M
FCF Margin
CLH
CLH
RVTY
RVTY
Q4 25
15.6%
21.0%
Q3 25
13.4%
17.2%
Q2 25
7.6%
16.0%
Q1 25
-8.2%
16.9%
Q4 24
16.9%
20.5%
Q3 24
9.3%
18.4%
Q2 24
5.2%
19.7%
Q1 24
-8.7%
20.0%
Capex Intensity
CLH
CLH
RVTY
RVTY
Q4 25
8.1%
2.6%
Q3 25
6.1%
2.6%
Q2 25
5.8%
2.6%
Q1 25
8.3%
2.4%
Q4 24
4.4%
3.4%
Q3 24
6.3%
3.3%
Q2 24
8.7%
3.2%
Q1 24
10.0%
2.7%
Cash Conversion
CLH
CLH
RVTY
RVTY
Q4 25
4.10×
1.85×
Q3 25
2.54×
2.97×
Q2 25
1.64×
2.49×
Q1 25
0.03×
3.03×
Q4 24
3.62×
1.84×
Q3 24
2.08×
1.57×
Q2 24
1.62×
2.87×
Q1 24
0.27×
5.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLH
CLH

Technical Services$479.3M32%
Safetly Kleen Environmental Services$252.9M17%
Fieldand Emergency Response$246.6M16%
Products$205.3M14%
Safety Kleen Sustainability Solutions Segment$188.4M13%
Safety Kleen Oil$132.6M9%

RVTY
RVTY

Immunodiagnostics$240.8M31%
Life Sciences$191.4M25%
Reproductive Health$149.3M19%
Segment Operating Income$132.0M17%
Software$62.3M8%

Related Comparisons